Therapy of autoimmune hepatitis

Best Practice and Research: Clinical Gastroenterology

Volumn 25, Issue 6, 2011, Pages 673-687

  Strassburg, Christian P ^a   Manns, Michael P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Budesonide; Corticosteroids; First pass effect; Immunosuppression; Transplantation

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; AZATHIOPRINE; BUDESONIDE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; DEFLAZACORT; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INTERFERON; METHOTREXATE; MYCOPHENOLIC ACID; PLACEBO; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; URSODEOXYCHOLIC ACID;

ABDOMINAL DISCOMFORT; ACNE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BLOOD TOXICITY; BONE NECROSIS; CARCINOGENICITY; CATARACT; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); CUSHINGOID SYNDROME; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DORSAL HUMP; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED CANCER; DRUG METABOLISM; DRUG TREATMENT FAILURE; EPIDEMIOLOGICAL DATA; FOLLOW UP; GROUPS BY AGE; HEPATITIS C; HIRSUTISM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; LEUKOPENIA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TOXICITY; LIVER TRANSPLANTATION; MENTAL DISEASE; MONOTHERAPY; MOON FACE; MULTICENTER STUDY (TOPIC); NAUSEA; NEPHROTOXICITY; NOSE MALFORMATION; OBESITY; OSTEOPENIA; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROGNOSIS; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; RISK FACTOR; SIDE EFFECT; STRIA; STRIA RUBRA; SURVIVAL RATE; TERATOGENICITY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIRUS HEPATITIS; VOMITING; WEIGHT GAIN;

GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RECURRENCE;

EID: 82255177224     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2011.08.003     Document Type: Article

References (99)

1. Waldenström J. Leber Blutproteine und Nahrungseiweisse Dtsch Gesellsch Verd Stoffw 15 1950 113 119
2. I.R. Mackay, L.I. Taft, and D.C. Cowling Lupoid hepatitis Lancet 2 1956 1323 1326
3. C.P. Strassburg, P. Obermayer-Straub, and M.P. Manns Autoimmunity in liver diseases Clin Rev Allergy Immunol 18 2000 127 139
4. F. Alvarez, P.A. Berg, and F.B. Bianchi International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938 (Pubitemid 29514229)
5. E.M. Hennes, M. Zeniya, and A.J. Czaja Simplified criteria for the diagnosis of autoimmune hepatitis Hepatology 48 2008 169 176 (Pubitemid 351975541)
6. C.P. Strassburg, and M.P. Manns Autoantibodies and autoantigens in autoimmune hepatitis Semin Liver Dis 22 2002 339 352
7. P.J. Johnson, and I.G. McFarlane Meeting report: international autoimmune hepatitis group Hepatology 18 1993 998 1005
8. C.P. Strassburg, and M.P. Manns Autoimmune hepatitis in the elderly: what is the difference? J Hepatol 45 2006 480 482 (Pubitemid 44307390)
9. R.T. Stravitz, J.H. Lefkowitch, and R.J. Fontana Autoimmune acute liver failure: proposed clinical and histological criteria Hepatology 53 2011 517 526
10. C.P. Strassburg, and M.P. Manns Autoimmune hepatitis versus viral hepatitis C Liver 15 1995 225 232
11. M.P. Manns, K.J. Griffin, and K.F. Sullivan LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase J Clin Invest 88 1991 1370 1378
12. M.P. Manns, E.F. Johnson, and K.J. Griffin Major antigen of liver kidney microsomal antibodies in idiopathic autoimmune hepatitis is cytochrome P450db1 J Clin Invest 83 1989 1066 1072 (Pubitemid 19080643)
13. C.P. Strassburg, P. Obermayer-Straub, and B. Alex Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis Gastroenterology 111 1996 1576 1586 (Pubitemid 26404222)
14. M. Manns, G. Gerken, and A. Kyriatsoulis Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen Lancet 1 1987 292 294 (Pubitemid 17009789)
15. E. Stechemesser, R. Klein, and P.A. Berg Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis Hepatology 18 1993 1 9 (Pubitemid 23193609)
16. C.S.E. Gelpi, and J.L. Rodriguez-Sanchez Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion Proc Natl Acad Sci U S A 89 1992 9739 9743
17. M. Volkmann, L. Martin, and A. Baurle Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis Hepatology 33 2001 591 596 (Pubitemid 32185221)
18. I. Wies, S. Brunner, and J. Henninger Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis [see comments] Lancet 355 2000 1510 1515 (Pubitemid 30237358)
19. M. Volkmann, D. Luithle, and H. Zentgraf SLA/LP/tRNP((Ser)Sec) antigen in autoimmune hepatitis: identification of the native protein in human hepatic cell extract J Autoimmun 34 2010 59 65
20. H.P. Dienes, H. Popper, and M. Manns Histologic features in autoimmune hepatitis Z Gastroenterol 27 1989 327 330
21. M. Nishioka, S.A. Morshed, and K. Kono Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatiis C J Hepatol 26 1997 992 1000 (Pubitemid 27242588)
22. M. Nishioka, S.A. Morshed, and I.G. McFarlane Geographical variation in the frequency and characteristics of autoimmune liver diseases 1998 Elsevier Amsterdam 413-424
23. E.L.R. Cancado, and G. Porta Autoimmune hepatitis in South America 2000 Kluwer Academic Publishers Dordrecht, Boston, London 82-92
24. A.P. Kirk, S. Jain, and S. Pocock Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis Gut 21 1980 7893
25. M.G. Geall, L.J. Schoenfield, and W.H.J. Summerskill Classification and treatment of chronic active liver disease Gastroenterology 55 1968 724 729
26. R.D. Soloway, W.H. Summerskill, and A.H. Baggenstoss Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis Gastroenterology 63 1972 820 833
27. G.V. Gregorio, B. Portman, and F. Reid Autoimmune hepatitis in childhood: a 20-year experience Hepatology 25 1997 541 547 (Pubitemid 27106430)
28. J.C. Homberg, N. Abuaf, and O. Bernard Chronic active hepatitis associated with anti liver/kidney microsome type 1: a second type of "autoimmune" hepatitis Hepatology 7 1987 1333 1339 (Pubitemid 18014211)
29. M.P. Manns, and C.P. Strassburg Autoimmune hepatitis: clinical challenges Gastroenterology 120 2001 1502 1517 (Pubitemid 32322325)
30. A.J. Czaja, and M.P. Manns Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis Gastroenterology 139 2010 58 72 e54
31. M.P. Manns, A.J. Czaja, and J.D. Gorham Diagnosis and management of autoimmune hepatitis Hepatology 51 2010 2193 2213
32. P.J. Johnson, I.G. McFarlane, and R. Williams Azathioprine for long-term maintenance of remission in autoimmune hepatitis N Engl.J Med 333 1995 958 963
33. G.A. Nikias, K.P. Batts, and A.J. Czaja The nature and prognostic implications of autoimmune hepatitis with acute presentation J Hepatol 21 1994 866 871 (Pubitemid 24374156)
34. J.L. Newton, A.D. Burt, and J.B. Park Autoimmune hepatitis in older patients Age Ageing 26 1997 441 444 (Pubitemid 28014908)
35. C. Schramm, S. Kanzler, and K.H. zum Buschenfelde Autoimmune hepatitis in the elderly Am J Gastroenterol 96 2001 1587 1591 (Pubitemid 32455095)
36. A.J. Czaja, and H.A. Carpenter Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly Hepatology 43 2006 532 538
37. A.J. Czaja, H.A. Carpenter, and P.J. Santrach Significance of HLA DR4 in type 1 autoimmune hepatitis Gastroenterology 105 1993 1502 1507 (Pubitemid 23315327)
38. T. Al-Chalabi, S. Boccato, and B.C. Portmann Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre J Hepatol 45 2006 575 583 (Pubitemid 44307378)
39. M. Prelog Aging of the immune system: a risk factor for autoimmunity? Autoimmun Rev 5 2006 136 139 (Pubitemid 43129545)
40. E. Talor, and N.R. Rose Hypothesis: the aging paradox and autoimmune disease Autoimmunity 8 1991 245 249
41. A. Thalen, and R. Brattsand Synthesis and anti-inflammatory properties of budesonide, a new non-halogenated glucocorticoid with high local activity Arzneimittelforschung 29 1979 1687 1690
42. A. Danielson, and H. Prytz Oral budesonide for treatment of autoimmune chronic hepatitis Aliment Pharmacol Ther 8 1994 585 590 (Pubitemid 24381357)
43. A.J. Czaja, and K.D. Lindor Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis Gastroenterology 119 2000 1312 1316
44. J. Wiegand, A. Schuler, and S. Kanzler Budesonide in previously untreated autoimmune hepatitis Liver Int 25 2005 927 934 (Pubitemid 41404011)
45. M.P. Manns, M. Woynarowski, and W. Kreisel Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis Gastroenterology 139 2010 1198 1206
46. J. Rebollo Bernardez, C. Cifuentes Mimoso, and A. Pinar Moreno Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis Rev Esp Enferm Dig 91 1999 630 638 (Pubitemid 29503032)
47. C.P. Strassburg, M.J. Bahr, and T. Becker Progress in immunosuppression Chirurg 79 2008 149 156
48. F. Alvarez, M. Ciocca, and C. Canero-Velasco Short-term cyclosporine induces a remission of autoimmune hepatitis in children J Hepatol 30 1999 222 227 (Pubitemid 29071183)
49. D. Debray, G. Maggiore, and J.P. Giradet Efficacy of cyclosporin A in children with type 2 autoimmune hepatits J Pediatr 135 1999 111 114 (Pubitemid 30180574)
50. N.F. Fernandez, A.G. Redeker, and J.M. Vierling Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis Am J Gastroenterol 94 1999 241 248 (Pubitemid 29063476)
51. M.A. Heneghan, and I.G. McFarlane Current and novel immunosuppressive therapy for autoimmune hepatitis Hepatology 35 2002 7 13 (Pubitemid 34032538)
52. D.H. Van Thiel, H. Wright, and P. Carroll Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial Am J Gastroenterol 90 1995 771 776
53. B.A. Aqel, V. Machicao, and B. Rosser Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis J Clin Gastroenterol 38 2004 805 809 (Pubitemid 39274185)
54. P.D. Richardson, P.D. James, and S.D. Ryder Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine J Hepatol 33 2000 371 375 (Pubitemid 30663373)
55. E.M. Hennes, Y.H. Oo, and C. Schramm Mycophenolate mofetil as second line therapy in autoimmune hepatitis? Am J Gastroenterol 103 2008 3063 3070
56. S. Kanzler, G. Gerken, and H.P. Dienes Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis - report of three cases Z Gastroenterol 35 1996 571 578
57. K. Umekita, S. Miyauchi, and S. Ueno Improvement of rheumatoid arthritis and autoimmune hepatitis in a patient treated with the tumor necrosis factor inhibitor, etanercept Intern Med 50 2011 1245 1249
58. C. Efe, T. Purnak, and E. Ozaslan Anti TNF-alpha therapy can be a novel treatment option in patients with autoimmune hepatitis Aliment Pharmacol Ther 32 115 2010 116 117 author reply
59. M. Ramos-Casals, P. Brito-Zeron, and M.J. Soto Autoimmune diseases induced by TNF-targeted therapies Best Pract Res Clin Rheumatol 22 2008 847 861
60. Y. Calmus, P. Gane, and P. Rouger Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid Hepatology 11 1990 12 15 (Pubitemid 20075095)
61. A.J. Czaja, H.A. Carpenter, and K.D. Lindor Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial Hepatology 30 1999 1381 1386
62. K. Nakamura, M. Yoneda, and S. Yokohama Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis [see comments] J Gastroenterol Hepatol 13 1998 490 495
63. C.P. Strassburg [Autoimmune liver diseases and their overlap syndromes] Praxis (Bern 2006 95 1994 1363 1381
64. K.M. Boberg, R.W. Chapman, and G.M. Hirschfield Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue J Hepatol 54 2011 374 385
65. C. Rust, and U. Beuers Overlap syndromes among autoimmune liver diseases World J Gastroenterol 14 2008 3368 3373
66. Z. Ben-Ari, A.P. Dhillon, and S. Sherlock Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis Hepatology 18 1993 10 15 (Pubitemid 23193610)
67. P. Angulo, O. El-Amin, and H.A. Carpenter Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis Am J Gastroenterol 96 2001 3021 3027 (Pubitemid 32959550)
68. L.A. Colombato, F. Alvarez, and J. Cote Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 107 1994 1839 1843 (Pubitemid 24357642)
69. O. Chazouilleres, D. Wendum, and L. Serfaty Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy Hepatology 28 1998 296 301 (Pubitemid 28363652)
70. J.C. Duclos-Vallee, A. Hadengue, and N. Ganne-Carrie Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A Dig Dis Sci 40 1995 1069 1073
71. T. Al-Chalabi, B.C. Portmann, and W. Bernal Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival Aliment Pharmacol Ther 28 2008 209 220 (Pubitemid 351861961)
72. M.G. Silveira, J.A. Talwalkar, and P. Angulo Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes Am J Gastroenterol 102 2007 1244 1250 (Pubitemid 46802005)
73. A.A. Gossard, and K.D. Lindor Development of autoimmune hepatitis in primary biliary cirrhosis Liver Int 27 2007 1086 1090 (Pubitemid 47399442)
74. R. Poupon, O. Chazouilleres, and C. Corpechot Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis Hepatology 44 2006 85 90 (Pubitemid 44049141)
75. P. Michieletti, I.R. Wanless, and A. Katz Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis Gut 35 1994 260 265 (Pubitemid 24092876)
76. G.V. Gregorio, B. Portmann, and J. Karani Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study Hepatology 33 2001 544 553 (Pubitemid 32185215)
77. A. Potthoff, K. Deterding, and C. Trautwein Steroid treatment for severe acute cryptogenic hepatitis Z Gastroenterol 45 2007 15 19 (Pubitemid 46202716)
78. O. Chazouilleres, D. Wendum, and L. Serfaty Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome J Hepatol 44 2006 400 406 (Pubitemid 43069223)
79. C.P. Strassburg, T. Becker, and J. Klempnauer Liver transplantation: deciding between need and donor allocation Internist (Berl) 45 2004 1233 1245
80. M. Ahmed, D. Mutimer, and M. Hathaway Liver transplantation for autoimmune hepatitis: a 12-year experience Transplant Proc 29 1997 496 (Pubitemid 27123503)
81. J. Neuberger, B. Portmann, and R. Calne Recurrence of autoimmune chronic active hepatitis following orthotopic liver grafting Transplantation 37 1984 363 365 (Pubitemid 14105426)
82. E. Prados, V. Cuervas-Mons, and M. De La Mata Outcome of autoimmune hepatitis after liver transplantation Transplantation 66 1998 1645 1650 (Pubitemid 29034985)
83. L. Sanchez-Urdazpal, A.J. Czaja, and B. Van Holk Prognostic features and role of liver transplantation in severe corticoid-treated autoimmune chronic active hepatitis Hepatology 15 1991 215 221
84. H.L. Tillmann, E. Jackel, and M.P. Manns Liver transplantation in autoimmune liver disease-selection of patients Hepatogastroenterology 46 1999 3053 3059
85. A. Vogel, E. Heinrich, and M.J. Bahr Long-term outcome of liver transplantation for autoimmune hepatitis Clin Transpl 18 2004 62 69 (Pubitemid 38195546)
86. C.P. Strassburg, and M.P. Manns Liver transplantation: indications and results Internist (Berl) 2009
87. V. Ratziu, D. Samuel, and M. Sebagh Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease J Hepatol 30 1999 131 141 (Pubitemid 29023662)
88. T.C. Schreuder, S.G. Hubscher, and J. Neuberger Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int 22 2009 144 152
89. J. Devlin, P. Donaldson, and B. Portman Recurrence of autoimmune hepatitis following liver transplantation Liver Transpl Surg 1 1995 162 165
90. M.P. Manns, and M.J. Bahr Recurrent autoimmune hepatitis after liver transplantation - when non-self becomes self Hepatology 32 2000 868 870
91. P. Milkiewicz, S.G. Hubscher, and G. Skiba Recurrence of autoimmune hepatitis after liver transplantation Transplantation 68 1999 253 256 (Pubitemid 29360286)
92. H.L. Wright, C.F. Bou-Abboud, and T. Hassanenstein Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease Transplantation 53 1992 136 139
93. G. Götz, R. Neuhaus, and W.O. Bechstein Recurrence of autoimmune hepatitis after liver transplantation Transplant Proc 31 1999 430 431 (Pubitemid 29127513)
94. M. Gautam, R. Cheruvattath, and V. Balan Recurrence of autoimmune liver disease after liver transplantation: a systematic review Liver Transpl 12 2006 1813 1824 (Pubitemid 44911808)
95. I.A. Rowe, K. Webb, and B.K. Gunson The impact of disease recurrence on graft survival following liver transplantation: a single centre experience Transpl Int 21 2008 459 465 (Pubitemid 351490169)
96. J. Campsen, M.A. Zimmerman, and J.F. Trotter Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal Liver Transpl 14 2008 1281 1286
97. N. Kerkar, N. Hadzic, and E.T. Davies De-novo autoimmune hepatitis after liver transplantation Lancet 351 1998 409 413 (Pubitemid 28064165)
98. M. Salcedo, J. Vaquero, and R. Banares Response to steroids in de novo autoimmune hepatitis after liver transplantation Hepatology 35 2002 349 356 (Pubitemid 34106374)
99. D.E. Jones, O.F. James, and B. Portmann Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis Hepatology 30 1999 53 57 (Pubitemid 29300568)